AMPH

Q: What is the price of Amphastar Pharmaceuticals (AMPH) today?

The price of Amphastar Pharmaceuticals (AMPH) today is R$ 164,44, with a variation of -36.99% compared to the last year. The price of Amphastar Pharmaceuticals (AMPH) started the year trading around R$ 201,24 and today it is at R$ 164,44. Follow the real-time price chart, the historical price of Amphastar Pharmaceuticals (AMPH), and stock data from Ibovespa and international markets.

Q: When does Amphastar Pharmaceuticals (AMPH) pay dividends?

Amphastar Pharmaceuticals (AMPH) did not distribute dividends in the last year.

Q: Amphastar Pharmaceuticals (AMPH) is it worth it?

Currently, Amphastar Pharmaceuticals (AMPH) is priced at R$ 164,44, with a P/E of 10,64%, representing a deviation of 15,60% from its historical average P/E. In the last year, the stock showed a variation of -36.99% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -36,99%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Amphastar Pharmaceuticals (AMPH)?

Investing in shares of Amphastar Pharmaceuticals (AMPH) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Amphastar Pharmaceuticals (AMPH) yield today?

The yield of Amphastar Pharmaceuticals (AMPH) was 35,63% in the last month, -36,99% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Amphastar Pharmaceuticals (AMPH) today, the total investment would be based on the current price of R$ 164,44.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 10.361,54In 5 years: R$ 16.444,28In 10 years: 16.444,28It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Amphastar Pharmaceuticals Inc.

Price

US$ 30,34

variation (12m)

-36,99%

p/l

10,64

p/vp

1,89

DIVIDEND YIELD

0,00%

quote AMPH

BVMF

AMPH

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of AMPH

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

35,63%

3 months

20,11%

1 year

-36,99%

2 years

-42,75%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

35,63%

3 months

19,51%

1 year

-40,13%

2 years

-47,82%

5 years

0,00%

10 years

0,00%

Indicators AMPH

check out the fundamentals of Amphastar Pharmaceuticals shares

P/L

10,64

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

1,98

Sector: 1,99 Industry: 2,90

P/VP

1,89

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

8,34%

Sector: -26,53% Industry: -56,94%

ROE

17,78%

Sector: -31,21% Industry: -45,34%

ROIC

11,03%

Sector: -404,40% Industry: -420,46%

Net Margin

18,64%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

49,86%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

25,14%

Sector: -23,10% Industry: -30,21%

P/EBITDA

6,14

Sector: 0,07 Industry: -2,60

P/EBIT

7,64

Sector: -1,37 Industry: -3,22

P/ASSETS

0,89

Sector: 1,23 Industry: 1,32

VPA

16,12

Sector: 3,66 Industry: 1,68

LPA

2,87

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,47

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

15,61%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

149,15%

Sector: - Industry: -

FAIR PRICE OF Amphastar Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 30,34

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

6,34%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

AMPH indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of AMPH with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history AMPH dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

21 years

Foundation: 2004

2014

Year of debut on the stock exchange - 11 years

354

Employees

The Company Amphastar Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,43 Billion, having a net worth of $ 757,48 Milhões.

With a total of 354 employees, the company is listed in the sector of Saúde and categorized in industry of Produtos Farmacêuticos.

In the last 12 months the Company had a revenue of $ 722,67 Milhões, which generated a profit in the amount of $ 134,71 Milhões.

As for its main indicators, the Company has a P/E ratio of 10,64, a P/B ratio of 1,89 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker AMPH.

Market value

US$ 1,43 Billion

Net worth

US$ 757,48 Milhões

US$ 757.480.000,00

Assets

US$ 1,62 Billion

US$ 1.615.330.000,00

Total Number of Shares

47,00 Milhões

47.000.000

Average Daily Trading Volume

US$ 554,74 Thousand

US$ 554.742,20

Sector

Saúde

Industry

Produtos Farmacêuticos

AMPH

AMPH revenue and profits

AMPH results

DRAG THE FRAME TO SEE MORE DATA

AMPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Amphastar Pharmaceuticals (AMPH) today?

The price of Amphastar Pharmaceuticals (AMPH) today is R$ 164,44, with a variation of -36.99% compared to the last year. The price of Amphastar Pharmaceuticals (AMPH) started the year trading around R$ 201,24 and today it is at R$ 164,44. Follow the real-time price chart, the historical price of Amphastar Pharmaceuticals (AMPH), and stock data from Ibovespa and international markets.

When does Amphastar Pharmaceuticals (AMPH) pay dividends?

Amphastar Pharmaceuticals (AMPH) did not distribute dividends in the last year.

Amphastar Pharmaceuticals (AMPH) is it worth it?

Currently, Amphastar Pharmaceuticals (AMPH) is priced at R$ 164,44, with a P/E of 10,64%, representing a deviation of 15,60% from its historical average P/E. In the last year, the stock showed a variation of -36.99% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -36,99%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Amphastar Pharmaceuticals (AMPH)?

Investing in shares of Amphastar Pharmaceuticals (AMPH) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Amphastar Pharmaceuticals (AMPH) yield today?

The yield of Amphastar Pharmaceuticals (AMPH) was 35,63% in the last month, -36,99% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Amphastar Pharmaceuticals (AMPH) today, the total investment would be based on the current price of R$ 164,44.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 10.361,54
In 5 years: R$ 16.444,28
In 10 years: 16.444,28

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AMPH

Amphastar Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of AMPH

check out the fundamentals of Amphastar Pharmaceuticals shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Inc.

Estados Unidos

21 years

2014

354

PROFIT X PRICE AMPH

AMPH results

AMPH cash flow

evolution of assets - AMPH

AMPH balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80